UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

Scientific reports, 2019-09, Vol.9 (1), p.13343-8, Article 13343

2019

Volltextzugriff (PDF)

Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients

Case reports in oncology, 2024-01, Vol.17 (1), p.208-216

2024

Volltextzugriff (PDF)

Large Breast Tumor Ulceration and Quality of Life in an 80-Year-Old Woman

Case reports in oncology, 2021-01, Vol.14 (1), p.580-584

2021

Volltextzugriff (PDF)

The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study

Breast cancer research and treatment, 2021-01, Vol.185 (1), p.125-134

2021

Volltextzugriff (PDF)

Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation

Case reports in oncology, 2023-01, Vol.16 (1), p.550-557

2023

Volltextzugriff (PDF)

Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast

Case reports in oncology, 2021-10, Vol.14 (3), p.1536-1541

2021

Volltextzugriff (PDF)

Pneumocystis Pneumonia and Acute Kidney Injury Induced by Everolimus Treatment in a Patient with Metastatic Breast Cancer

Case reports in oncology, 2020-01, Vol.13 (1), p.170-175

2020

Volltextzugriff (PDF)

Enrichment of Immune-Related Genes in Aggressive Primary Breast Angiosarcoma: A Case Report

Case reports in oncology, 2023-07, Vol.16 (1), p.461-470

2023

Volltextzugriff (PDF)

Concurrent Bowen’s Disease of the Nipple and Breast Cancer

Case reports in oncology, 2020-11, Vol.13 (3), p.1410-1414

2020

Volltextzugriff (PDF)

Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy

Case reports in oncology, 2019-09, Vol.12 (3), p.814-819

2019

Volltextzugriff (PDF)

Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.510-510

2018

Volltextzugriff (PDF)

Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis

Breast cancer research and treatment, 2015-01, Vol.149 (1), p.277-284

2015

Volltextzugriff (PDF)

A randomized phase II study evaluating pyridoxine for the prevention of hand–foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer

Breast cancer (Tokyo, Japan), 2018-11, Vol.25 (6), p.729-735

2018

Volltextzugriff (PDF)

Comparison of the Modified Immunohistochemical Marker Score and 21-Gene Recurrence Score Assay in Patients with Estrogen Receptor-Positive Breast Cancer

Oncology, 2022-03, Vol.100 (3), p.155-162

2022

Volltextzugriff (PDF)

Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3743-3752

2020

Volltextzugriff (PDF)

Abstract PO1-24-02: Enhancement of TGF-β Receptor Inhibitor Efficacy through CD44 Suppression in Claudin-low Breast Cancer

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO1-24-02-PO1-24-02

2024

Volltextzugriff (PDF)

Trastuzumab and pertuzumab in combination with eribulin mesylate or a taxane as first-line chemotherapeutic treatment for HER2-positive, locally advanced or metastatic breast cancer: Results of a multicenter, randomized, non-inferiority phase 3 trial in Japan (JBCRG-M06/EMERALD)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.1007-1007

2024

Volltextzugriff (PDF)

An exploratory study on prediction of risk for abemaciclib-induced interstitial lung disease or hepatotoxicity by specific human leukocyte antigen alleles

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3087-3087

2024

Volltextzugriff (PDF)

A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.523-523

2023

Volltextzugriff (PDF)

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

Oncotarget, 2017-11, Vol.8 (61), p.103671-103681

2017

Volltextzugriff (PDF)

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Breast cancer research and treatment, 2014-08, Vol.147 (1), p.103-112

2014

Volltextzugriff (PDF)

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

Breast cancer research and treatment, 2024, Vol.203 (2), p.225-234

2024

Volltextzugriff (PDF)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.538-538

2023

Volltextzugriff (PDF)

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Breast cancer research and treatment, 2023-12, Vol.202 (3), p.473-483

2023

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(54)
Berichte
(10)

Sprache

Englisch
(63)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

Complexities in Adjuvant Endocrine Therapy for Breast Cancer in Female-to-Male Transgender Patients

Large Breast Tumor Ulceration and Quality of Life in an 80-Year-Old Woman

The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study

Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation

Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study

Pathological Complete Response to Neoadjuvant Chemotherapy in a Patient with HER2-Positive Squamous Cell Carcinoma of the Breast

Pneumocystis Pneumonia and Acute Kidney Injury Induced by Everolimus Treatment in a Patient with Metastatic Breast Cancer

Enrichment of Immune-Related Genes in Aggressive Primary Breast Angiosarcoma: A Case Report

Concurrent Bowen’s Disease of the Nipple and Breast Cancer

Response of Estrogen-Receptor-Positive Metastatic Breast Cancer to Olaparib in Late-Line Therapy

Evaluation of trastuzumab without chemotherapy as a postoperative adjuvant therapy in HER2-positive elderly breast cancer patients: Randomized controlled trial (RESPECT)

Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis

A randomized phase II study evaluating pyridoxine for the prevention of hand–foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer

Comparison of the Modified Immunohistochemical Marker Score and 21-Gene Recurrence Score Assay in Patients with Estrogen Receptor-Positive Breast Cancer

Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients

Abstract PO1-24-02: Enhancement of TGF-β Receptor Inhibitor Efficacy through CD44 Suppression in Claudin-low Breast Cancer

Trastuzumab and pertuzumab in combination with eribulin mesylate or a taxane as first-line chemotherapeutic treatment for HER2-positive, locally advanced or metastatic breast cancer: Results of a multicenter, randomized, non-inferiority phase 3 trial in Japan (JBCRG-M06/EMERALD)

An exploratory study on prediction of risk for abemaciclib-induced interstitial lung disease or hepatotoxicity by specific human leukocyte antigen alleles

A randomized controlled trial comparing primary tumor resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group study JCOG1017

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer

Suchergebnisse filtern